Nateglinide
USP/1457607 - United States Pharmacopeia (USP) Reference Standard
Synonym: Fastic; N-
CAS Number: 105816-04-4
Empirical Formula (Hill Notation): C19H27NO3
Molecular Weight: 317.42
MDL Number: MFCD00875706
Linear Formula: C19H27NO3
Product Type: Chemical
| API family | nateglinide |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C19H27NO3/c1-13(2)15-8 |
| InChI key | OELFLUMRDSZNSF-BRWVUGGUSA |
| manufacturer/tradename | USP |
| SMILES string | CC(C)[C@@H]1CC[C@H](CC1)C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Biochem/physiol Actions: | Nateglinide is a Kir6.2/SUR1 channel inhibitor and antidiabetic. |
| Biochem/physiol Actions: | Nateglinide is a Kir6.2/SUR1 channel inhibitor and antidiabetic. It is selective for the SUR1 subtype, which is found on pancreatic islet cells. Nateglinide evokes KATP channel-dependent insulin secretion (50-200 μM) in the absence and presence of insulin. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Other Notes: | Sales restrictions may apply. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |

